1Sahn SA. Corticosteroids in chronic bronchitis and puhnonary emphysema. Chest, 1978,73:389-396.
2van Grunsven PM, van Schayck CP, Derenne JP, et al. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease : a meta-analysis. Thorax, 1999,54:7-14.
3Vestbo J, Scrensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease:a randomised controlled trial. Lancet, 1999,353 : 1819-1823.
4Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European respiratory society study on chronic obstructive puhnonary disease. N Engl J Med, 1999,340 : 1948-1953.
5The Lung Health Study Research Group. Effect of inhaled triameinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med ,2000,343 : 1902-1909.
6Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind,placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive puhnonary disease : the ISOLDE trial. BMJ ,2000,320 : 1297-1303.
7Hattotuwa KL, Gizycki M J, Ansari TW, et al. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med ,2002,165 : 1592-1596.
8Culpitt SV,Maziak W,Loukidis S,et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1999,160 : 1635-1639.
9Calverley P, Pauwe|s R, Vestboet J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease :a randomised controlled trial. Lancet,2003,361:449-456.
10Calverley PM, Anderson JA, Celli B, et al, Sahneterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med,2007 ,356 :775-789.
